Hyperlactatemia — Early Lactate-Directed Therapy in the Intensive Care Unit (ICU)
Citation(s)
Blow O, Magliore L, Claridge JA, Butler K, Young JS The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. J Trauma. 1999 Nov;47(5):964-9.
Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005 Mar 5-11;365(9462):871-5. Erratum in: Lancet. 2005 Jul 9-15;366(9480):122.
Retlich S, Duval V, Graefe-Mody U, Jaehde U, Staab A Impact of target-mediated drug disposition on Linagliptin pharmacokinetics and DPP-4 inhibition in type 2 diabetic patients. J Clin Pharmacol. 2010 Aug;50(8):873-85. doi: 10.1177/0091270009356444. Epub 2010 Feb 16.
Williams DM, Jarrold C Brief report: Predicting inner speech use amongst children with autism spectrum disorder (ASD): the roles of verbal ability and cognitive profile. J Autism Dev Disord. 2010 Jul;40(7):907-13. doi: 10.1007/s10803-010-0936-8.
Early Lactate-Directed Therapy on the ICU: A Randomized Controlled Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.